Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
Harding
S
S
D020256:Choroidal Neovascularization / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy; D018579:Patient Selection; D010778:Photochemotherapy / Q000592:standards*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin